Tag Archives: BIOC

Maxim Group Reiterates a Buy Rating on Biocept (BIOC)

Maxim Group analyst Jason McCarthy reiterated a Buy rating on Biocept (BIOC – Research Report) yesterday and set a price target of $1.00. The company’s shares closed last Tuesday at $0.75. According to TipRanks.com, McCarthy is a top 100 analyst

Maxim Group Releases a Buy Rating on Biocept (BIOC)

Maxim Group analyst Jason McCarthy assigned a Buy rating to Biocept (BIOC – Research Report) today and set a price target of $1.00. The company’s shares closed last Tuesday at $0.69. According to TipRanks.com, McCarthy is a 5-star analyst with

Maxim Group Issues a Buy Rating on Biocept (BIOC)

Maxim Group analyst Jason McCarthy assigned a Buy rating to Biocept (BIOC – Research Report) today and set a price target of $1.00. The company’s shares closed last Monday at $0.60. According to TipRanks.com, McCarthy has currently no stars on

Biocept (BIOC) Gets a Buy Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Biocept (BIOC – Research Report), with a price target of $1.00. The company’s shares closed last Monday at $0.51, close to its 52-week low of

Maxim Group Keeps Their Buy Rating on Biocept (BIOC)

Maxim Group analyst Jason McCarthy maintained a Buy rating on Biocept (BIOC – Research Report) yesterday and set a price target of $1.00. The company’s shares closed last Monday at $0.37, close to its 52-week low of $0.23. According to

Biocept Inc (BIOC) Gets a Buy Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Biocept Inc (BIOC – Research Report), with a price target of $3. The company’s shares closed yesterday at $0.91, close to its 52-week low of